Zolmitriptan
Zolmitriptan is a prescription nasal spray medication used to treat migraine headaches. It works by narrowing blood vessels in the brain and reducing inflammation. Available in 2.5 mg and 5 mg doses per spray, it's a generic version manufactured by Padagis Israel Pharmaceuticals Ltd. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Zolmitriptan is a prescription nasal spray medication used to treat migraine headaches. It works by narrowing blood vessels in the brain and reducing inflammation. Available in 2.5 mg and 5 mg doses per spray, it's a generic version manufactured by Padagis Israel Pharmaceuticals Ltd. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Zolmitriptan",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Zolmitriptan — ANDA 205074 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205074"
}
]
|
| identifier | ANDA205074 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Zolmitriptan |
